Efficient Generation of Monoclonal Antibodies Against Major Structural Proteins of Rabies Virus with Suckling Mouse Brain Antigen
Authors:
- 1 April 2014
- journal article
- research article
- Published by SAGE Publications in Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
- Vol. 33 (2) , 94-100
Abstract
The rabies virus is a neurotropic virus that causes fatal disease in humans and animals. However, not all commercial antibodies against rabies virus (RABV) structural proteins are generally available, and production of high-quality monoclonal antibodies (MAbs) requires high purification of virus particles and special facilities and is time-consuming. By using RABV-infected suckling mouse brain as antigens in this study, 11 hybridoma cells secreting MAbs against RABV were obtained, which showed strong reactivity with RABV-infected Vero cells in immunofluorescence assay. Among the 11 MAbs, three MAbs (1B11, 1C8, and 8H12) showed a neutralizing effect to RABV, while MAb 4B7 recognized the recombinant nucleoprotein (N) of RABV expressed in Vero cells; seven MAbs (1H3, 3H7, 4E7, 4G3, 5A10, 6C9, and 7B3) reacted specifically with phosphoprotein (P) of RABV. The MAbs developed in this study will be useful in establishing a diagnostic test and study on the interactions between RABV and its host.Keywords
This publication has 21 references indexed in Scilit:
- Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potencyMolecular Immunology, 2014
- Preparation and identification of anti-rabies virus monoclonal antibodiesVirologica Sinica, 2012
- Novel monoclonal antibodies that bind to wild and fixed rabies virus strainsJournal of Virological Methods, 2011
- Characterization of a panel of anti-phosphoprotein monoclonal antibodies generated against the raccoon strain of rabies virusVirus Research, 2010
- Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technologyMicrobiology and Immunology, 2008
- The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposureJournal of Immunological Methods, 2000
- Use of anti-glycoprotein monoclonal antibodies to characterize rabies virus in formalin-fixed tissuesJournal of Virological Methods, 1999
- Development of Human Monoclonal Antibodies to RabiesHybridoma, 1994
- Human Monoclonal Antibodies Specific for the Rabies Virus Glycoprotein and N ProteinJournal of General Virology, 1990
- Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants.Proceedings of the National Academy of Sciences of the United States of America, 1978